Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammography | 9 | 2017 | 309 | 0.850 |
Why?
|
Radiology | 5 | 2021 | 97 | 0.680 |
Why?
|
Ultrasonography, Mammary | 5 | 2015 | 39 | 0.560 |
Why?
|
Magnetic Resonance Imaging | 6 | 2016 | 2220 | 0.530 |
Why?
|
Ovarian Cysts | 1 | 2013 | 9 | 0.490 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2013 | 21 | 0.490 |
Why?
|
Tomography, X-Ray Computed | 5 | 2013 | 2323 | 0.480 |
Why?
|
Breast Neoplasms | 9 | 2017 | 1531 | 0.480 |
Why?
|
Low Back Pain | 3 | 1997 | 45 | 0.460 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 267 | 0.420 |
Why?
|
Pelvic Pain | 1 | 2011 | 11 | 0.410 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2012 | 163 | 0.360 |
Why?
|
Ultrasonography | 6 | 2016 | 452 | 0.360 |
Why?
|
Breast Density | 3 | 2017 | 21 | 0.340 |
Why?
|
Liver Cirrhosis | 1 | 2012 | 301 | 0.340 |
Why?
|
Liver Neoplasms | 1 | 2012 | 334 | 0.320 |
Why?
|
Taste | 2 | 1998 | 49 | 0.300 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2005 | 25 | 0.280 |
Why?
|
Mass Screening | 4 | 2017 | 836 | 0.280 |
Why?
|
Phlebography | 1 | 2005 | 31 | 0.280 |
Why?
|
Sensitivity and Specificity | 7 | 2016 | 1751 | 0.270 |
Why?
|
Breast Diseases | 2 | 2016 | 40 | 0.260 |
Why?
|
Female | 32 | 2020 | 38003 | 0.260 |
Why?
|
Leg | 1 | 2005 | 191 | 0.250 |
Why?
|
Venous Thrombosis | 1 | 2005 | 124 | 0.250 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2015 | 61 | 0.240 |
Why?
|
Practice Guidelines as Topic | 3 | 2017 | 772 | 0.240 |
Why?
|
Internship and Residency | 2 | 2021 | 596 | 0.230 |
Why?
|
Pulmonary Embolism | 1 | 2005 | 253 | 0.230 |
Why?
|
ROC Curve | 4 | 2013 | 392 | 0.220 |
Why?
|
Middle Aged | 25 | 2017 | 21115 | 0.220 |
Why?
|
Humans | 41 | 2021 | 68504 | 0.210 |
Why?
|
Family Leave | 1 | 2021 | 2 | 0.210 |
Why?
|
Sick Leave | 1 | 2021 | 6 | 0.210 |
Why?
|
Policy | 1 | 2021 | 58 | 0.200 |
Why?
|
Adult | 23 | 2017 | 21373 | 0.190 |
Why?
|
Ultrasonography, Doppler | 3 | 2009 | 57 | 0.180 |
Why?
|
Ribonucleases | 3 | 2000 | 25 | 0.180 |
Why?
|
Carbonated Beverages | 1 | 1998 | 9 | 0.170 |
Why?
|
Aged | 16 | 2017 | 14841 | 0.170 |
Why?
|
Sweetening Agents | 1 | 1998 | 23 | 0.170 |
Why?
|
Mobile Health Units | 1 | 2017 | 18 | 0.160 |
Why?
|
Personal Satisfaction | 1 | 1998 | 123 | 0.160 |
Why?
|
Coronavirus Infections | 1 | 2020 | 143 | 0.160 |
Why?
|
Intervertebral Disc Displacement | 1 | 1997 | 17 | 0.160 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 154 | 0.150 |
Why?
|
Temporomandibular Joint | 1 | 2016 | 18 | 0.150 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2016 | 20 | 0.150 |
Why?
|
Pandemics | 1 | 2020 | 346 | 0.150 |
Why?
|
Residence Characteristics | 1 | 1998 | 252 | 0.150 |
Why?
|
Aged, 80 and over | 9 | 2016 | 4843 | 0.140 |
Why?
|
Radiologists | 1 | 2016 | 35 | 0.140 |
Why?
|
Receptors, Progesterone | 2 | 2013 | 57 | 0.140 |
Why?
|
Wine | 1 | 1995 | 4 | 0.140 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 177 | 0.140 |
Why?
|
Receptors, Estrogen | 2 | 2013 | 142 | 0.130 |
Why?
|
Diagnostic Imaging | 3 | 2007 | 201 | 0.130 |
Why?
|
Graft Rejection | 2 | 2009 | 458 | 0.130 |
Why?
|
Receptor, ErbB-2 | 2 | 2013 | 128 | 0.130 |
Why?
|
Fractures, Bone | 2 | 1993 | 132 | 0.130 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 237 | 0.130 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1995 | 346 | 0.120 |
Why?
|
Male | 16 | 2016 | 37265 | 0.120 |
Why?
|
Ovary | 1 | 2013 | 99 | 0.120 |
Why?
|
Brachytherapy | 2 | 2011 | 79 | 0.120 |
Why?
|
Radiology Information Systems | 1 | 1993 | 21 | 0.120 |
Why?
|
Practice Patterns, Physicians' | 1 | 2017 | 503 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2013 | 1139 | 0.110 |
Why?
|
Blood Proteins | 3 | 2000 | 94 | 0.110 |
Why?
|
Quality Improvement | 1 | 2016 | 413 | 0.110 |
Why?
|
Radiographic Image Enhancement | 2 | 1993 | 208 | 0.110 |
Why?
|
Sentinel Surveillance | 1 | 2012 | 20 | 0.110 |
Why?
|
Occupational Health Nursing | 2 | 2009 | 2 | 0.110 |
Why?
|
Biliary Dyskinesia | 1 | 2011 | 7 | 0.110 |
Why?
|
Pneumonia | 1 | 1993 | 110 | 0.110 |
Why?
|
Mesenteric Lymphadenitis | 1 | 2011 | 2 | 0.100 |
Why?
|
Ureteral Calculi | 1 | 2011 | 4 | 0.100 |
Why?
|
Diverticulitis | 1 | 2011 | 6 | 0.100 |
Why?
|
Uterine Perforation | 1 | 2011 | 3 | 0.100 |
Why?
|
Clinical Competence | 1 | 2016 | 656 | 0.100 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 369 | 0.100 |
Why?
|
Intestinal Obstruction | 1 | 2011 | 36 | 0.100 |
Why?
|
Uterus | 1 | 2011 | 77 | 0.100 |
Why?
|
Eosinophils | 2 | 2000 | 60 | 0.100 |
Why?
|
Appendicitis | 1 | 2011 | 55 | 0.100 |
Why?
|
Kidney Transplantation | 2 | 2009 | 839 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2011 | 119 | 0.090 |
Why?
|
Ascitic Fluid | 1 | 2009 | 22 | 0.090 |
Why?
|
Paracentesis | 1 | 2009 | 25 | 0.090 |
Why?
|
Ascites | 1 | 2009 | 38 | 0.090 |
Why?
|
Colitis | 1 | 2011 | 156 | 0.090 |
Why?
|
Onchocerciasis | 1 | 1989 | 4 | 0.090 |
Why?
|
Agricultural Workers' Diseases | 1 | 2009 | 14 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2017 | 7263 | 0.090 |
Why?
|
Kidney Diseases | 2 | 2009 | 307 | 0.080 |
Why?
|
World Health Organization | 1 | 2008 | 53 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2008 | 85 | 0.080 |
Why?
|
Granular Cell Tumor | 1 | 2008 | 9 | 0.080 |
Why?
|
Disease Progression | 1 | 2012 | 1037 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2011 | 285 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2011 | 286 | 0.080 |
Why?
|
Pregnancy | 2 | 2011 | 2331 | 0.080 |
Why?
|
Myelography | 2 | 1997 | 10 | 0.080 |
Why?
|
Evidence-Based Practice | 1 | 2009 | 146 | 0.080 |
Why?
|
Occupational Health Services | 1 | 2007 | 14 | 0.080 |
Why?
|
Emergency Medical Technicians | 1 | 2007 | 14 | 0.080 |
Why?
|
Radiography | 2 | 2020 | 572 | 0.080 |
Why?
|
Fires | 1 | 2007 | 21 | 0.080 |
Why?
|
Volunteers | 1 | 2007 | 30 | 0.080 |
Why?
|
Opportunistic Infections | 1 | 2007 | 33 | 0.080 |
Why?
|
Chronic Disease | 1 | 2012 | 1329 | 0.080 |
Why?
|
United States | 4 | 2021 | 7333 | 0.070 |
Why?
|
Contrast Media | 2 | 2011 | 594 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 1465 | 0.070 |
Why?
|
Dairying | 1 | 2006 | 6 | 0.070 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2006 | 22 | 0.070 |
Why?
|
Rural Health Services | 1 | 2007 | 101 | 0.070 |
Why?
|
Organ Transplantation | 1 | 2007 | 110 | 0.070 |
Why?
|
Regression Analysis | 2 | 1997 | 737 | 0.070 |
Why?
|
Coronary Disease | 1 | 2007 | 358 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2007 | 444 | 0.070 |
Why?
|
Language | 1 | 2006 | 120 | 0.070 |
Why?
|
Skin Neoplasms | 1 | 2009 | 375 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2016 | 2077 | 0.060 |
Why?
|
Colonography, Computed Tomographic | 1 | 2004 | 23 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 1997 | 1046 | 0.060 |
Why?
|
Research Design | 2 | 2017 | 729 | 0.060 |
Why?
|
Prospective Studies | 3 | 2016 | 3702 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2005 | 344 | 0.060 |
Why?
|
Colonoscopy | 1 | 2004 | 156 | 0.060 |
Why?
|
Pulmonary Artery | 1 | 2005 | 323 | 0.060 |
Why?
|
Radiation Oncology | 1 | 2021 | 12 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2009 | 1615 | 0.050 |
Why?
|
Stents | 1 | 2006 | 657 | 0.050 |
Why?
|
Radiology, Interventional | 1 | 2021 | 21 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2000 | 71 | 0.050 |
Why?
|
Program Evaluation | 2 | 2016 | 502 | 0.050 |
Why?
|
Congresses as Topic | 1 | 2020 | 85 | 0.050 |
Why?
|
Surgical Instruments | 1 | 2000 | 44 | 0.050 |
Why?
|
Eosinophil Granule Proteins | 3 | 2000 | 5 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2000 | 626 | 0.040 |
Why?
|
Betacoronavirus | 1 | 2020 | 116 | 0.040 |
Why?
|
Aspartame | 1 | 1998 | 1 | 0.040 |
Why?
|
Biomarkers, Tumor | 2 | 2013 | 507 | 0.040 |
Why?
|
Stem Cell Factor | 1 | 1998 | 39 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2004 | 560 | 0.040 |
Why?
|
Sucrose | 1 | 1998 | 58 | 0.040 |
Why?
|
Arachidonic Acids | 1 | 1998 | 97 | 0.040 |
Why?
|
Biopsy | 2 | 2016 | 538 | 0.040 |
Why?
|
Serotonin | 1 | 1998 | 144 | 0.040 |
Why?
|
Preoperative Care | 1 | 2000 | 275 | 0.040 |
Why?
|
Arterial Occlusive Diseases | 2 | 2009 | 134 | 0.040 |
Why?
|
Mast Cells | 1 | 1998 | 113 | 0.040 |
Why?
|
Intervertebral Disc Chemolysis | 1 | 1997 | 1 | 0.040 |
Why?
|
Nurse's Role | 2 | 2009 | 66 | 0.040 |
Why?
|
Lumbosacral Region | 1 | 1997 | 18 | 0.040 |
Why?
|
Absenteeism | 1 | 1997 | 27 | 0.040 |
Why?
|
Patient Care Planning | 1 | 1997 | 108 | 0.040 |
Why?
|
Spine | 1 | 1997 | 46 | 0.040 |
Why?
|
Analgesia, Epidural | 1 | 1997 | 40 | 0.040 |
Why?
|
Social Class | 1 | 1997 | 127 | 0.040 |
Why?
|
Diagnostic Tests, Routine | 1 | 1997 | 51 | 0.040 |
Why?
|
Feedback | 1 | 2016 | 90 | 0.040 |
Why?
|
Absorptiometry, Photon | 1 | 2016 | 83 | 0.040 |
Why?
|
Accreditation | 1 | 2016 | 72 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2007 | 3256 | 0.040 |
Why?
|
Premenopause | 1 | 2016 | 57 | 0.040 |
Why?
|
New York | 2 | 2007 | 223 | 0.040 |
Why?
|
Physical Therapy Modalities | 1 | 1997 | 133 | 0.040 |
Why?
|
Postmenopause | 1 | 2016 | 92 | 0.040 |
Why?
|
Observer Variation | 1 | 2016 | 330 | 0.030 |
Why?
|
Medical Oncology | 1 | 2016 | 110 | 0.030 |
Why?
|
Linear Models | 1 | 1997 | 521 | 0.030 |
Why?
|
Fibroblasts | 1 | 2000 | 902 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 1995 | 192 | 0.030 |
Why?
|
Calcinosis | 1 | 2016 | 241 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2016 | 652 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 214 | 0.030 |
Why?
|
Random Allocation | 1 | 1995 | 442 | 0.030 |
Why?
|
Guideline Adherence | 1 | 2016 | 284 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 1997 | 1054 | 0.030 |
Why?
|
X-Ray Film | 1 | 1993 | 16 | 0.030 |
Why?
|
Logistic Models | 1 | 1997 | 1419 | 0.030 |
Why?
|
Biomedical Research | 1 | 2016 | 310 | 0.030 |
Why?
|
Neoplasm Grading | 1 | 2013 | 110 | 0.030 |
Why?
|
Lasers | 1 | 1993 | 61 | 0.030 |
Why?
|
Risk Factors | 2 | 2017 | 5719 | 0.030 |
Why?
|
Risk Assessment | 2 | 2011 | 2004 | 0.030 |
Why?
|
Pilot Projects | 1 | 2016 | 1341 | 0.030 |
Why?
|
Curriculum | 1 | 2016 | 575 | 0.030 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 439 | 0.030 |
Why?
|
Gallbladder Emptying | 1 | 2011 | 4 | 0.030 |
Why?
|
Imino Acids | 1 | 2011 | 7 | 0.030 |
Why?
|
Cholecystokinin | 1 | 2011 | 29 | 0.030 |
Why?
|
Technetium | 1 | 2011 | 38 | 0.030 |
Why?
|
Child | 2 | 2013 | 6400 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2007 | 7026 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2011 | 125 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 160 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2012 | 798 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 333 | 0.020 |
Why?
|
Health Fairs | 1 | 2009 | 1 | 0.020 |
Why?
|
Eosinophil Peroxidase | 1 | 1989 | 1 | 0.020 |
Why?
|
Onchocerca | 1 | 1989 | 4 | 0.020 |
Why?
|
New England | 1 | 2009 | 16 | 0.020 |
Why?
|
Cytoplasmic Granules | 1 | 1989 | 19 | 0.020 |
Why?
|
Nursing Evaluation Research | 1 | 2009 | 46 | 0.020 |
Why?
|
Models, Nursing | 1 | 2009 | 23 | 0.020 |
Why?
|
Peroxidases | 1 | 1989 | 28 | 0.020 |
Why?
|
Neurotoxins | 1 | 1989 | 30 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2011 | 1039 | 0.020 |
Why?
|
Exocytosis | 1 | 1989 | 34 | 0.020 |
Why?
|
Rare Diseases | 1 | 2008 | 41 | 0.020 |
Why?
|
Adolescent | 2 | 2013 | 8903 | 0.020 |
Why?
|
Urethral Obstruction | 1 | 2008 | 8 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2008 | 219 | 0.020 |
Why?
|
Mastectomy, Segmental | 1 | 2007 | 63 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2007 | 191 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2007 | 55 | 0.020 |
Why?
|
Workplace | 1 | 2007 | 75 | 0.020 |
Why?
|
Peptides | 2 | 2000 | 455 | 0.020 |
Why?
|
Vermont | 1 | 2006 | 21 | 0.020 |
Why?
|
Self Care | 1 | 2009 | 252 | 0.020 |
Why?
|
Age Distribution | 1 | 2007 | 319 | 0.020 |
Why?
|
Pennsylvania | 1 | 2006 | 46 | 0.020 |
Why?
|
Primary Prevention | 1 | 2007 | 115 | 0.020 |
Why?
|
Cause of Death | 1 | 2007 | 241 | 0.020 |
Why?
|
Career Mobility | 1 | 2006 | 34 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2009 | 424 | 0.020 |
Why?
|
Health Services Research | 1 | 2007 | 209 | 0.020 |
Why?
|
Population Surveillance | 1 | 2007 | 285 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 2007 | 166 | 0.020 |
Why?
|
Workload | 1 | 2006 | 103 | 0.020 |
Why?
|
Telemedicine | 1 | 1993 | 698 | 0.020 |
Why?
|
Equipment Design | 1 | 2006 | 500 | 0.020 |
Why?
|
Kidney | 1 | 2009 | 944 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 514 | 0.010 |
Why?
|
Inflammation | 1 | 1989 | 1029 | 0.010 |
Why?
|
Eosinophil-Derived Neurotoxin | 1 | 2000 | 2 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2000 | 117 | 0.010 |
Why?
|
Intestines | 1 | 2000 | 114 | 0.010 |
Why?
|
Concanavalin A | 1 | 1998 | 22 | 0.010 |
Why?
|
Ionophores | 1 | 1998 | 25 | 0.010 |
Why?
|
Endopeptidases | 1 | 1998 | 51 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1998 | 78 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2000 | 742 | 0.010 |
Why?
|
Histamine | 1 | 1998 | 52 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 1998 | 91 | 0.010 |
Why?
|
Gene Expression | 1 | 2000 | 769 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 1998 | 217 | 0.010 |
Why?
|
Young Adult | 1 | 2009 | 5708 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1998 | 490 | 0.010 |
Why?
|
Animals | 2 | 1998 | 20849 | 0.010 |
Why?
|
Proteins | 1 | 2000 | 472 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1998 | 397 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2000 | 2668 | 0.010 |
Why?
|
Calcium | 1 | 1998 | 927 | 0.010 |
Why?
|
Cell Line | 1 | 1998 | 1747 | 0.010 |
Why?
|
Cell Differentiation | 1 | 1998 | 1034 | 0.010 |
Why?
|
Computer Terminals | 1 | 1993 | 4 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 1993 | 100 | 0.010 |
Why?
|
Rats | 1 | 1998 | 5282 | 0.010 |
Why?
|
Mice | 1 | 1998 | 8461 | 0.000 |
Why?
|
Surveys and Questionnaires | 1 | 1993 | 2798 | 0.000 |
Why?
|